Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-74 - Characteristics of T Cell Receptor Repertoire of Lung Cancer Patients
09:45 - 09:45 | Presenter: Naixin Liang | Author(s): Huaxia Yang, Ziqi Jia, Xiaoying Yang, Pancheng Wu, Yanyu Wang, Yadong Wang, Zhongxing Bing, Lei Cao, Zhili Cao, Dejian Gu, Rongrong Chen, Xuefeng Xia, Shanqing Li
- Abstract
Loading...
-
+
P1.12 - Small Cell Lung Cancer/NET
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P1.12-10 - The Genomic Profiles of Small Cell Lung Cancer in East Asian
09:45 - 09:45 | Presenter: Rongrong Chen | Author(s): Zheng-bo Song, Xiao-fei Wang, Jin Li, Lian-peng Chang, Yan-Fang Guan, Xuefeng Xia, Xin Yi
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-11 - A Prospective Multicenter Study of Target-Capture Deep Sequencing in Paired Tissue and ctDNA to Guide EGFR-Mutated Lung Cancer Treatment
09:45 - 09:45 | Presenter: Shun Lu | Author(s): Xinghao Ai, Jiexia Zhang, Wen Lin, Jiuwei Cui, Congying Xie, Anwen Liu, Xiaohua Hu, qiong Zhao, chuangzhou Rao, yuansheng Zang, xiaohua Hu, Junping Zhang, Caixia Liu, Lian-peng Chang, Ningning He, Rongrong Chen, Xuefeng Xia, Xin Yi
- Abstract
Loading... -
+
P1.14-38 - Identification of FGFR1-3 Fusions in Lung Cancers Using Comprehensive Next-Generation Sequencing
09:45 - 09:45 | Presenter: Gen Lin | Author(s): Mingming Yuan, Panwen Tian, Likun Chen, Chunmei Shi, Yifen Wu, Fenglei Yu, Lingjun Zhu, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P1.14-47 - ctDNA NGS for Guiding Crizotinib Treatment in ALK-Rearranged Advanced NSCLC Patients (Pts)
09:45 - 09:45 | Presenter: Yong He | Author(s): Jun Zhao, Caixia Liu, Rongrong Chen, Xuefeng Xia
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.01 - Clinical and Genomic Features of Chinese Lung Cancer Patients with Germline Mutations
15:45 - 15:50 | Presenter: Wenying Peng | Author(s): Jin Li, Lian-peng Chang, Jing Bai, Yanyan Zhang, Yan-Fang Guan, Xingxiang Pu, Meilin Jiang, Jun Cao, Bolin Chen, Xuefeng Xia, Xin Yi, Jianjun Zhang, Lin Wu
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-54 - Characteristic of MSI-H Lung Cancer Patients Identified with Targeted Next-Generation Sequencing
10:15 - 10:15 | Presenter: Rongrong Chen | Author(s): Wen Lin, Yuting Yi, Gen Lin, Jun Zhao, Mingming Yuan, Yan-Fang Guan, Xuefeng Xia
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-09 - Concurrent TP53 Mutation Adversely Impact the Efficacy of Crizotinib in ROS1-Rearranged Lung Cancer Patients
10:15 - 10:15 | Presenter: Gen Lin | Author(s): Huamin Xu, Jun Zhao, Jinliang Kong, Xinghao Ai, Fenglei Yu, Kaiqi Du, Lingjun Zhu, Lin Li, Hongxia Ma, Qiaoli Wang, Huanhuan Xiong, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P2.14-38 - ATAD2B-ALK, a Novel Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing (NGS)
10:15 - 10:15 | Presenter: Hao Wu | Author(s): Huiwen Bai, Wanqiu Jia, Xianglan Jin, Hailong Mao, Da Wu, Rongrong Chen, Xuefeng Xia
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.02 - Genomic Origin and EGFR-TKI Efficacy of Pulmonary Adenosquamous Carcinoma
14:35 - 14:40 | Presenter: Gen Lin | Author(s): Chao Li, Pansong Li, Wenzhang Fang, Haipeng Xu, Yuhua Gong, Zhengfei Zhu, Yi Hu, Wenhua Liang, Qian Chu, Wen-Zhao Zhong, Lin Wu, Huijuan Wang, Zhijie Wang, Ziming Li, Jie Lin, Yan-Fang Guan, Xuefeng Xia, Xin Yi, Qian Miao, Biao Wu, Kang Jiang, Xiaobin Zheng, Weifeng Zhu, Xinlong Zheng, Huang Peisha, Xiao Wenjin, Dan Hu, Longfeng Zhang, Xirong Fan, Tony Mok, Cheng Huang
- Abstract
Loading...
